Concepedia

Time-limited Approval

Time-Limited Approval is a regulatory authorization mechanism that permits the provisional marketing of a medical product based on preliminary evidence of efficacy and safety, contingent upon the sponsor's fulfillment of post-approval requirements within a specified timeframe.

2

Publications

65

Citations

5

Authors

4

Institutions

Publications per year

2017–2026

1

Parents

Publications

2

1–2 of 2

Authors

5

  1. KY
    Kazuo Yano

    Waseda University, Japan

    1 publications · 38 citations

    1

    h-index

  2. YF
    Yasuyuki Fujita

    Hokkaido University, Japan

    1 publications · 27 citations

    1

    h-index

  3. MY
    Masayuki Yamato

    Tokyo Women's Medical University, Japan

    1 publications · 38 citations

    1

    h-index

  4. AK
    Atsuhiko Kawamoto

    Foundation for Biomedical Research and Innovation, Japan

    1 publications · 27 citations

    1

    h-index

  5. YJ
    Yoji Jokura

    Tokyo Women's Medical University, Japan

    1 publications · 38 citations

    1

    h-index

1–5 of 5

Institutions

4

  1. Tokyo Women's Medical University

    Tokyo, Japan

    1 h-index

    3 publications

    114 citations

  2. Translational Research Informatics Center (Japan)

    Kobe, Japan

    1 h-index

    1 publications

    27 citations

  3. Foundation for Biomedical Research and Innovation

    Kobe, Japan

    1 h-index

    2 publications

    54 citations

  4. Waseda University

    Tokyo, Japan

    1 h-index

    3 publications

    114 citations

1–4 of 4

Venues

  1. 1

    h-index

  2. Clinical Pharmacology & Therapeutics

    CPT · 1 publications · 27 citations

    1

    h-index

1–2